COVID-19: A review of newly formed viral clades, pathophysiology, therapeutic strategies and current vaccination tasks.
Today, the world population is facing an existential threat by an invisible enemy known as severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) or COVID-19. It is highly contagious and has infected a larger fraction of human population across the globe on various routes of transmission. The detailed knowledge of the SARS-CoV-2 structure and clinical aspects offers an important insight into the evolution of infection, disease progression and helps in executing the different therapies effectively. Herein, we have discussed in detail about the genome structure of SARS-CoV-2 and its role in the proteomic rational spread of different muted species and pathogenesis in infecting the host cells. The mechanisms behind the viral outbreak and its immune response, the availability of existing diagnostics techniques, the treatment efficacy of repurposed drugs and the emerging vaccine trials for the SARS-CoV-2 outbreak also have been highlighted. Furthermore, the possible antiviral effects of various herbal products and their extracted molecules in inhibiting SARS-CoV-2 replication and cellular entry are also reported. Finally, we conclude our opinion on current challenges involved in the drug development, bulk production of drug/vaccines and their storage requirements, logistical procedures and limitations related to dosage trials for larger population.
['Murugan|Chandran|C|', 'Ramamoorthy|Sharmiladevi|S|', 'Kuppuswamy|Guruprasad|G|', 'Murugan|Rajesh Kumar|RK|', 'Sivalingam|Yuvaraj|Y|', 'Sundaramurthy|Anandhakumar|A|']
Vaccines SARS-CoV-2 And drugs Phytocomponent Spike protein mutation Variants